The gene encoding for the insulin-growth factor 1 (IGF1) was expressed in significantly increased magnitude by CSF cells of patients treated intrathecally with methotrexate compared to untreated MS patients (Figure 5A, patients' characteristics in Table 1). Here, IGF1 is linked to myeloid sarcoma.